Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance—protocol for a systematic review

BACKGROUND: Testicular cancer is primarily treated with the surgical removal of the affected testis. About 50 % of testicular cancer patients present with a stage I seminoma. If no chemo- or radiotherapy as adjuvant treatment is initiated after orchiectomy, 15–20 % of these patients will develop met...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunath, Frank, Spek, Annabel, Jensen, Katrin, Zengerling, Friedemann, Schmidt, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683799/
https://www.ncbi.nlm.nih.gov/pubmed/26684760
http://dx.doi.org/10.1186/s13643-015-0167-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683799/
https://www.ncbi.nlm.nih.gov/pubmed/26684760
http://dx.doi.org/10.1186/s13643-015-0167-3

Ejemplares similares